Showing 271-280 of 593 results for "".
Systemic Effects of UV Radiation: The Case for Apoptosis of Peripheral Blood Mononuclear Cells
https://practicaldermatology.com/topics/general-topics/PD0709_11-php/22806/Mechanisms of UV-mediated tumorigenesis and development are not fully understood. Findings suggest apoptosis of peripheral blood mononuclear cells may play a role.Biologics in Psoriasis: The Next Generation
https://practicaldermatology.com/topics/psoriasis/biologics-in-psoriasis-the-next-generation/20807/Get familiar with the IL-23 monoclonal antibodies.Use of Hylenex to Treat Microstomia in CREST Syndrome: A Case Study and Call to Action
https://practicaldermatology.com/youngmd-connect/resident-resource-center/proton-pump-inhibitor-induced-dermal-hypersensitivity-reaction-masquerading-as-an-arthropod-bite-reaction/23915/Physician Spotlight: Désirée Ratner, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-desiree-ratner-md-1/23263/Biosimilars: What's Coming for Labeling?
https://practicaldermatology.com/topics/practice-management/biosimilars-whats-coming-for-labeling/20934/The public comment period on draft labeling guidance will end next month.TherapeuticsFocus:Psoriasis
https://practicaldermatology.com/topics/practice-management/therapeuticsfocuspsoriasis/21024/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21093/Re-Considering the Psychological Components of Psoriasis
https://practicaldermatology.com/topics/psoriasis/re-considering-the-psychological-components-of-psoriasis/22962/With convincing data that show that psoriasis directly inhibits patients' daily activities and quality of life, clinicians must emphasize trust and empathy.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21764/First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.